Longeveron Inc Share Price Today: Live Updates & Key Insights

Longeveron Inc share price today is $0.97, up -11.71%. The stock opened at $1.0863 against the previous close of $1.11, with an intraday high of $1.09 and low of $0.9607.

Longeveron Inc Share Price Chart

Longeveron Inc

us-stock
To Invest in {{usstockname}}
us-stock

Longeveron Inc Share Price Performance

$0.97 -0.1171(-11.71%) LGVN at 23 Mar 2026 01:58 PM Biotechnology
Lowest Today 0.9607
Highest Today 1.09
Today’s Open 1.0863
Prev. Close 1.11
52 Week High 1.92
52 Week Low 0.48
Day’s Range: Low 0.9607 High 1.09
52-Week Range: Low 0.48 High 1.92
1 day return -
1 Week return +13.13
1 month return +82.5
3 month return +85.2
6 month return +27.87
1 year return -46.08
3 year return -96.46
5 year return -98.61
10 year return -

Longeveron Inc Institutional Holdings

Vanguard Group Inc 3.29

Vanguard Total Stock Mkt Idx Inv 1.69

Geode Capital Management, LLC 0.93

Vanguard Institutional Extnd Mkt Idx Tr 0.46

UBS Group AG 0.42

Fidelity Extended Market Index 0.33

State Street Corp 0.30

NT Ext Equity Mkt Idx Fd - L 0.22

Capital Investment Advisory Services, LLC 0.17

Commonwealth Equity Services Inc 0.17

Hamilton Point Investment Advisors, LLC 0.15

Moneta Group Investment Advisors Inc 0.14

Citadel Advisors Llc 0.13

Fidelity Total Market Index 0.11

Northern Trust Corp 0.10

Fidelity Series Total Market Index 0.10

Virtu Financial LLC 0.10

Susquehanna International Group, LLP 0.09

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.09

HRT FINANCIAL LLC 0.08

Lido Advisors, LLC 0.07

Spartan Extended Market Index Pool F 0.07

Northern Trust Extended Eq Market Idx 0.07

TWO SIGMA SECURITIES, LLC 0.07

BlackRock Inc 0.07

Bank of Montreal 0.07

BMO Capital Markets Corp. 0.07

Spartan Total Market Index Pool G 0.03

Steward Partners Investment Advisory, LLC 0.02

Tower Research Capital LLC 0.01

Fidelity Nasdaq Composite Index 0.01

Blackrock Extended Mkt Fund CF 0.01

Extended Equity Market Fund K 0.01

NT Ext Equity Mkt Idx Fd - NL 0.00

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.00

Extended Equity Market Fund M 0.00

State St US Extended Mkt Indx NL Cl C 0.00

State St US Ttl Mkt Indx NL Cl A 0.00

NT US Market Cap Idx Fd - L 0.00

SSgA U.S. Total Market Index Strategy 0.00

Longeveron Inc Market Status

Strong Buy: 0

Buy: 3

Hold: 0

Sell: 0

Strong Sell: 0

Longeveron Inc Fundamentals

Market Cap 28.70 M

PB Ratio 2.9399

PE Ratio 0.0

Enterprise Value 21.04 M

Total Assets 10.26 M

Volume 1571488

Longeveron Inc Company Financials

Annual Revenue FY23:767000 0.8M, FY22:1222000 1.2M, FY21:1306000 1.3M, FY20:5629531 5.6M, FY19:5639466 5.6M

Annual Profit FY23:168000 0.2M, FY22:497000 0.5M, FY21:590000 0.6M, FY20:1826270 1.8M, FY19:1754076 1.8M

Annual Net worth FY23:-19842000 -19.8M, FY22:-19627000 -19.6M, FY21:-17164000 -17.2M, FY20:-3791220 -3.8M, FY19:-2995507 -3.0M

Quarterly Revenue Q3/2025:137000 0.1M, Q2/2025:316000 0.3M, Q1/2025:381000 0.4M, Q3/2024:773000 0.8M, Q2/2024:468000 0.5M

Quarterly Profit Q3/2025:125000 0.1M, Q2/2025:146000 0.1M, Q1/2025:275000 0.3M, Q3/2024:682000 0.7M, Q2/2024:344000 0.3M

Quarterly Net worth Q3/2025:-7221000 -7.2M, Q2/2025:-5028000 -5.0M, Q1/2025:-5011000 -5.0M, Q3/2024:-4419000 -4.4M, Q2/2024:-3413000 -3.4M

About Longeveron Inc & investment objective

Company Information Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.

Organisation Biotechnology

Employees 25

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Longeveron Inc FAQs

What is the share price of Longeveron Inc today?

The current share price of Longeveron Inc is $0.97.

Can I buy Longeveron Inc shares in India?

Yes, Indian investors can buy Longeveron Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Longeveron Inc shares in India?

You can easily invest in Longeveron Inc shares from India by:

Can I buy fractional shares of Longeveron Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Longeveron Inc?

Longeveron Inc has a market cap of $28.70 M.

In which sector does Longeveron Inc belong?

Longeveron Inc operates in the Biotechnology sector.

What documents are required to invest in Longeveron Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Longeveron Inc?

The PE ratio of Longeveron Inc is N/A and the PB ratio is 2.94.